ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,658, issued on Aug. 18, was assigned to Zensun (Shanghai) Science & Technology Co. Ltd. (Shanghai).
"Compositions and methods for treating heart failure" was invented by Mingdong Zhou (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for treating chronic heart failure patients using the medication comprising neuregulin. The methods comprise first performing a companion diagnostic test of each patient before treatment; and then providing a suitable treatment to the patient according to the results of the companion diagnostic test. When the result of the test is within a favorite treatment zone, the patien...